title: Prostate cancer: Predicting response to androgen receptor signalling inhibition.
authors.affiliation: Department of Urology, University of California, Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Evans
authors.affiliation: Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA.
authors.forename: Primo N
authors.initials: PN
authors.lastname: Lara
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019046:Bone Marrow Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D010669:Phenylthiohydantoin